缓解PaxlovidTM诱导的药物 - 药物相互作用毒性:一个"in silico"洞察力
1Department of Chemistry, National Dong Hwa University, Hualien, Taiwan.
Frontiers in pharmacology
|December 11, 2024
概括
里托纳维尔 (Ritonavir) 是一种药物.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物运输 药物运输 药物运输
- 计算化学计算化学
背景情况:
- 帕克斯洛维德 (PaxlovidTM) 的成分里托纳维尔 (Ritonavir) 具有显著的药物相互作用副作用.
- 这些相互作用需要探索Nirmatrelvir,PaxlovidTM的另一个组成部分的替代注射途径.
- 由于里托纳维尔的药理动力学特征,目前的施用方法可能会限制治疗潜力.
研究的目的:
- 评估尼尔马特里尔维尔在通过皮肤给药方面的潜力.
- 通过计算建模来研究Nirmatrelvir的皮肤透性.
- 确定尼尔马特里尔维尔的替代药物输送策略,以改善抗COVID-19治疗.
主要方法:
- 利用多个化模型来预测皮肤的透性.
- 采用计算方法模拟皮肤屏障的药物行为.
- 评估了与通过皮肤递送药物相关的物理化学特性.
主要成果:
- 在 silico 模型中预测了对Nirmatrel.vir有利的皮肤透性.
- 计算分析表明,尼尔马特里尔维尔可以有效地穿透皮肤屏障.
- 这些发现表明,Nirmatrelvir的可行透皮输送途径是可行的.
结论:
- 尼尔马特里尔维尔显示了通过皮肤给药的潜力.
- 通过皮肤输送的尼马特里尔维尔可以作为口服PaxlovidTM的替代品.
- 这种方法可以通过绕过Ritonavir相互作用来提高抗COVID-19治疗的疗效.
相关概念视频
Agonism and Antagonism: Quantification
322
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
322
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Structure-Activity Relationships and Drug Design
554
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
554
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
81
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
81
Combined Effects of Drugs: Antagonism
8.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.3K
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K


